PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of August 7, 2026, PRCT trades at $19.62 with a market cap of $1.10B and a P/E ratio of -11.20. PRCT moved +3.62% today. Year to date, PRCT is -34.88%; over the trailing twelve months it is -56.16%. Its 52-week range spans $16.67 to $92.92. Analyst consensus is buy with an average price target of $27.83. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PRCT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $19.62 |
| Market Cap | $1.10B |
| P/E Ratio | -11.20 |
| EPS | $-1.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $92.92 |
| 52-Week Low | $16.67 |
| Volume | 2.05M |
| Avg Volume | 0 |
| Revenue (TTM) | $308.05M |
| Net Income | $-95.57M |
| Gross Margin | 63.70% |
9 analysts cover PRCT: 0 strong buy, 4 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.83.